Current position

Renaissance Technologies LLC’s Teladoc Health Inc (TDOC) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Renaissance Technologies LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2019Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares8.18MHighest verified quarter-end share count
Quarters reported23Verified quarters with shares above zero
What happened?

Renaissance Technologies LLC first reported Teladoc Health Inc in Q4 2019. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Renaissance Technologies LLC currently reports 8.07M shares. The latest verified filing showed: Sold 0.2% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 0.2% of the position−12.70K shares · 8.07M shares remained
Filing context

Quarter-end price $8.48 · Estimated holding basis $13.73

Q1 2026
Bought 1.3% more+107.40K shares · 8.09M shares reported after the change
Filing context

Quarter-end price $5.45 · Estimated holding basis $13.73

Q4 2025
Sold 2.4% of the position−198.70K shares · 7.98M shares remained
Filing context

Quarter-end price $7.00 · Estimated holding basis $13.84

Q3 2025
Bought 11.7% more+855.30K shares · 8.18M shares reported after the change
Filing context

Quarter-end price $7.73 · Estimated holding basis $13.84

Q2 2025
Bought 11.8% more+775.30K shares · 7.32M shares reported after the change
Filing context

Quarter-end price $8.71 · Estimated holding basis $14.55

Q1 2025
Bought 15.4% more+871.70K shares · 6.55M shares reported after the change
Filing context

Quarter-end price $7.96 · Estimated holding basis $15.24

Portfolio importance

How important is Teladoc Health Inc in Renaissance Technologies LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.1%Q2 2026
Current rank#240of 3140 reported positions
Peak portfolio weight0.2%Q2 2022
Best historical rank#114Q2 2022
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$6.282026-09-17

Market context only; not an investor transaction price.

Latest filing quarter-end price$8.48Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$13.73Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-13
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Renaissance’s secret models, complete trading book, exact trade dates or execution prices.